Jill DeSimone, Director at Praxis Precision Medicines, Inc. (PRAX), sold 11,600 shares at $301.44 ($3.6M) on 2026-06-24, disclosed to the SEC on 2026-06-26.
Scheduled sale ($3.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $301.44 | 10 | $3K | 0.1% |
| 2 | $303.13 | 120 | $36K | 1.0% |
| 3 | $305.31 | 320 | $98K | 2.7% |
| 4 | $306.77 | 683 | $210K | 5.8% |
| 5 | $308.24 | 1,240 | $382K | 10.6% |
| 6 | $309.38 | 999 |
| $309K |
| 8.6% |
| 7 | $310.89 | 1,750 | $544K | 15.1% |
| 8 | $311.91 | 2,854 | $890K | 24.7% |
| 9 | $312.83 | 1,004 | $314K | 8.7% |
| 10 | $313.66 | 504 | $158K | 4.4% |
| 11 | $314.90 | 1,279 | $403K | 11.2% |
| 12 | $315.70 | 837 | $264K | 7.3% |
| Total | $311.32 avg | 11,600 | $3.6M | 100% |